Differential expression of lncRNA in the serum of ankylosing spondylitis patients

Q4 Medicine
Li Zhuojie, Qiu Yong, Qian Bang-ping
{"title":"Differential expression of lncRNA in the serum of ankylosing spondylitis patients","authors":"Li Zhuojie, Qiu Yong, Qian Bang-ping","doi":"10.3760/CMA.J.ISSN.0253-2352.2019.18.006","DOIUrl":null,"url":null,"abstract":"Objective \nTo investigate the differential expression of lncRNA in the serum of ankylosing spondylitis (AS) patients, with the goal of findingnew potential biomarkers for the diagnosis and targeted treatment of AS. \n \n \nMethods \nA total of 19 AS patients and 19 age-matched healthy controls treated at Nanjing Drum Tower Hospitalfrom January 2017 to September 2017 were recruited. Average age were 38.74±7.42 (range, 25-51) and 37.00±6.86 (range, 26-50). High-throughput lncRNA sequencing technology was used to detect differently expressed lncRNAs in the serum of 3 AS patients and 3 healthy controls. Target lncRNAs for further validation were selected according to the P values and fold-changes. In the rest of the serum samples (16 AS patients and 16 healthy controls), Trizol-based technique was used to extract total RNA, and after reverse transcription to obtain cDNA, RT-qPCR was preformed to confirm the sequencing results. \n \n \nResults \nUsing high-throughput lncRNA sequencing, a total of 41 up-regulated and 2 down-regulated lncRNAs were detected in the serum of AS patients. After sorted by the P values, 4 lncRNAswith a fold-change larger than 2 were chosen as the target genes for RT-qPCR (ENST00000365494.1, P=2.6×10-277, fold-change: 2.05; ENST00000364938.1, P=2.49×10-77, fold-change: 2.19; ENST 00000363046.1, P=2.67×10-29, fold-change: 2.51; ENST00000384756.1, P=6.17×10-21, fold-change: 2.28). RT-qPCR results showed the relative expression of lncRNA ENST00000365494.1 was 1.80±0.22 (P=0.304), lncRNA ENST00000364938.1was 0.78±0.07 (P=0.417), lncRNA ENST00000363046.1was 1.28±0.24 (P=0.793), lncRNA ENST00000384756.1 was 1.52±0.25 (P=0.611)and tendency of up-regulation was found in 3 of them, which was consistent with the sequencing results. However, the difference did not achieve statistical significance. \n \n \nConclusion \nSequencing result could not be confirmed by RT-qPCR with a larger sample size, which implied the differential expression of lncRNA might not exist in the peripheral blood of AS patients, and further studies regarding lncRNA in AS could focus more on its differential expression and function in the focal tissue. \n \n \nKey words: \nSpondylitis, ankylosing; Regulatory sequences, ribonucleic acid; Gene expression","PeriodicalId":36405,"journal":{"name":"中华骨科杂志","volume":"39 1","pages":"1142-1148"},"PeriodicalIF":0.0000,"publicationDate":"2019-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华骨科杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.0253-2352.2019.18.006","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objective To investigate the differential expression of lncRNA in the serum of ankylosing spondylitis (AS) patients, with the goal of findingnew potential biomarkers for the diagnosis and targeted treatment of AS. Methods A total of 19 AS patients and 19 age-matched healthy controls treated at Nanjing Drum Tower Hospitalfrom January 2017 to September 2017 were recruited. Average age were 38.74±7.42 (range, 25-51) and 37.00±6.86 (range, 26-50). High-throughput lncRNA sequencing technology was used to detect differently expressed lncRNAs in the serum of 3 AS patients and 3 healthy controls. Target lncRNAs for further validation were selected according to the P values and fold-changes. In the rest of the serum samples (16 AS patients and 16 healthy controls), Trizol-based technique was used to extract total RNA, and after reverse transcription to obtain cDNA, RT-qPCR was preformed to confirm the sequencing results. Results Using high-throughput lncRNA sequencing, a total of 41 up-regulated and 2 down-regulated lncRNAs were detected in the serum of AS patients. After sorted by the P values, 4 lncRNAswith a fold-change larger than 2 were chosen as the target genes for RT-qPCR (ENST00000365494.1, P=2.6×10-277, fold-change: 2.05; ENST00000364938.1, P=2.49×10-77, fold-change: 2.19; ENST 00000363046.1, P=2.67×10-29, fold-change: 2.51; ENST00000384756.1, P=6.17×10-21, fold-change: 2.28). RT-qPCR results showed the relative expression of lncRNA ENST00000365494.1 was 1.80±0.22 (P=0.304), lncRNA ENST00000364938.1was 0.78±0.07 (P=0.417), lncRNA ENST00000363046.1was 1.28±0.24 (P=0.793), lncRNA ENST00000384756.1 was 1.52±0.25 (P=0.611)and tendency of up-regulation was found in 3 of them, which was consistent with the sequencing results. However, the difference did not achieve statistical significance. Conclusion Sequencing result could not be confirmed by RT-qPCR with a larger sample size, which implied the differential expression of lncRNA might not exist in the peripheral blood of AS patients, and further studies regarding lncRNA in AS could focus more on its differential expression and function in the focal tissue. Key words: Spondylitis, ankylosing; Regulatory sequences, ribonucleic acid; Gene expression
lncRNA在强直性脊柱炎患者血清中的差异表达
目的探讨lncRNA在强直性脊柱炎(AS)患者血清中的差异表达,为AS的诊断和靶向治疗寻找新的潜在生物标志物。方法选取2017年1月至2017年9月南京鼓楼医院收治的AS患者19例和年龄匹配的健康对照19例。平均年龄分别为38.74±7.42(25 ~ 51岁)和37.00±6.86(26 ~ 50岁)。采用高通量lncRNA测序技术检测3例AS患者和3例健康对照血清中不同表达的lncRNA。根据P值和折叠变化选择进一步验证的lncrna。其余血清样本(16例AS患者和16例健康对照),采用trizol技术提取总RNA,逆转录获得cDNA后,进行RT-qPCR确认测序结果。结果通过高通量lncRNA测序,在AS患者血清中共检测到41个上调lncRNA, 2个下调lncRNA。经P值排序后,选择4个fold-change大于2的lncrna作为RT-qPCR的靶基因(ENST00000365494.1, P=2.6×10-277, fold-change: 2.05;ENST00000364938.1, P=2.49×10-77, fold-change: 2.19;ENST 00000363046.1, P=2.67×10-29, fold-change: 2.51;ENST00000384756.1, P=6.17×10-21, fold-change: 2.28)。RT-qPCR结果显示,lncRNA ENST00000365494.1的相对表达量为1.80±0.22 (P=0.304), lncRNA enst00000364938.1的相对表达量为0.78±0.07 (P=0.417), lncRNA enst00000363046.1的相对表达量为1.28±0.24 (P=0.793), lncRNA ENST00000384756.1的相对表达量为1.52±0.25 (P=0.611),其中3个基因有上调的趋势,与测序结果一致。但差异不具有统计学意义。结论样本量较大的RT-qPCR无法证实测序结果,提示AS患者外周血中可能不存在lncRNA的差异表达,进一步研究lncRNA在AS中的差异表达及其在局灶组织中的功能可进一步关注。关键词:脊柱炎;强直性;调节序列,核糖核酸;基因表达
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
中华骨科杂志
中华骨科杂志 Medicine-Surgery
CiteScore
0.80
自引率
0.00%
发文量
8153
期刊介绍:
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信